These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 19137907)

  • 1. Design, synthesis and structure-activity relationship studies of 6-phenyl-4,5-dihydro-3(2H)-pyridazinone derivatives as cardiotonic agents.
    Wang T; Dong Y; Wang LC; Xiang BR; Chen Z; Qu LB
    Arzneimittelforschung; 2008; 58(11):569-73. PubMed ID: 19137907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and bioactivity of 6-phenyl-4,5-dihydro-3(2H)-pyridazinone derivatives.
    Wang T; Dong Y; Wang LC; Chen Z
    Arzneimittelforschung; 2007; 57(10):641-6. PubMed ID: 18074757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiotonic agents. 6. Synthesis and inotropic activity of 2,4-dihydro-5-[4-(1H-imidazol-1-yl)phenyl]-3H-pyrazol-3-ones: ring-contracted analogues of imazodan (CI-914).
    Sircar I; Morrison GC; Burke SE; Skeean R; Weishaar RE
    J Med Chem; 1987 Oct; 30(10):1724-8. PubMed ID: 3656349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyridazinone derivatives: design, synthesis, and in vitro vasorelaxant activity.
    Abouzid K; Abdel Hakeem M; Khalil O; Maklad Y
    Bioorg Med Chem; 2008 Jan; 16(1):382-9. PubMed ID: 17905589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiotonic agents. 3. Synthesis and biological activity of novel 6-(substituted 1H-imidazol-4(5)-yl)-3(2H)-pyridazinones.
    Sircar I; Bobowski G; Bristol JA; Weishaar RE; Evans DB
    J Med Chem; 1986 Feb; 29(2):261-7. PubMed ID: 3950907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of new 4,5-3(2H)pyridazinone derivatives and their cardiotonic, hypotensive, and platelet aggregation inhibition activities.
    Amin EN; Abdel-Alim AA; Abdel-Moty SG; El-Shorbagi AN; Abdel-Rahman MSh
    Arch Pharm Res; 2010 Jan; 33(1):25-46. PubMed ID: 20191341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, antitubercular, antifungal and antibacterial activities of 6-substituted phenyl-2-(3'-substituted phenyl pyridazin-6'-yl)-2,3,4,5-tetrahydropyridazin-3-one.
    Islam M; Siddiqui AA; Rajesh R
    Acta Pol Pharm; 2008; 65(3):353-62. PubMed ID: 18646555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of novel 6-substituted-3(2H)-pyridazinone-2-acetyl-2-(substituted/-nonsubstituted benzal)hydrazone derivatives and acetylcholinesterase and butyrylcholinesterase inhibitory activities in vitro.
    Utku S; Gökçe M; Orhan I; Sahin MF
    Arzneimittelforschung; 2011; 61(1):1-7. PubMed ID: 21355440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evoked changes in cardiovascular function in rats by infusion of levosimendan, OR-1896 [(R)-N-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)acetamide], OR-1855 [(R)-6-(4-aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one], dobutamine, and milrinone: comparative effects on peripheral resistance, cardiac output, dP/dt, pulse rate, and blood pressure.
    Segreti JA; Marsh KC; Polakowski JS; Fryer RM
    J Pharmacol Exp Ther; 2008 Apr; 325(1):331-40. PubMed ID: 18171907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on cardiotonic agents. VI. Synthesis of novel 4,5-dihydro-3(2H)-pyridazinone derivatives carrying some benzoheterocycles at the 6-position.
    Nomoto Y; Takai H; Ohno T; Kubo K
    Chem Pharm Bull (Tokyo); 1991 Feb; 39(2):352-7. PubMed ID: 2054859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the benzimidazole derivatives pimobendan and 2-(4-hydroxy-phenyl)-5-(5-methyl-3-oxo-4,5-dihydro-2H-6- pyridazinyl) benzimidazole . HCl on phosphodiesterase activity and force of contraction in guinea-pig hearts.
    Berger C; Meyer W; Scholz H; Starbatty J
    Arzneimittelforschung; 1985; 35(11):1668-73. PubMed ID: 2418846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiotonic agents. 4. Synthesis and biological evaluation of N-substituted 2,4,4a,5-tetrahydro-3H-indeno[1,2-c]pyridazin-3-ones: rigid structures derived from CI-930 and analogues.
    Sircar I; Duell BL; Cain MH; Burke SE; Bristol JA
    J Med Chem; 1986 Nov; 29(11):2142-8. PubMed ID: 3783575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect on contractility of skinned fibres from mammalian heart and smooth muscle by a new benzimidazole derivative, 4,5-dihydro-6-[2-(4-methoxyphenyl)-1H-benzimidazol-5-yl]-5-methy l-3(2H )- pyridazinone.
    Rüegg JC; Pfitzer G; Eubler D; Zeugner C
    Arzneimittelforschung; 1984; 34(12):1736-8. PubMed ID: 6543308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiotonic agents. 9. Synthesis and biological evaluation of a series of (E)-4,5-dihydro-6-[2-[4-(1H-imidazol-1-yl)phenyl]ethenyl]-3 (2H)-pyridazinones: a novel class of compounds with positive inotropic, antithrombotic, and vasodilatory activities for the treatment of congestive heart failure.
    Sircar I; Steffen RP; Bobowski G; Burke SE; Newton RS; Weishaar RE; Bristol JA; Evans DB
    J Med Chem; 1989 Feb; 32(2):342-50. PubMed ID: 2536438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of cardiotonic agents. 8. Synthesis and biological activities of optically active 6-(4-(benzylamino)-7-quinazolinyl)-4,5-dihydro-5-methyl-3(2H)- pyridazinone (KF15232).
    Nomoto Y; Takai H; Ohno T; Nagashima K; Yao K; Yamada K; Kubo K; Ichimura M; Mihara A; Kase H
    J Med Chem; 1996 Jan; 39(1):297-303. PubMed ID: 8568820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and evaluation of anti-inflammatory and analgesic activities of a novel series of substituted-N-(4-methyl-2-oxo-2H-chromen-7-yl) benzamides.
    Ronad PM; Hunashal RD; Darbhamalla S; Maddi VS
    Arzneimittelforschung; 2008; 58(12):641-6. PubMed ID: 19202735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and vasodilatory activity of some amide derivatives of 6-(4-carboxymethyloxyphenyl)-4,5-dihydro-3(2H)-pyridazinone.
    Bansal R; Kumar D; Carron R; de la Calle C
    Eur J Med Chem; 2009 Nov; 44(11):4441-7. PubMed ID: 19589624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some pyrrole substituted aryl pyridazinone and phthalazinone derivatives and their antihypertensive activities.
    Demirayak S; Karaburun AC; Beis R
    Eur J Med Chem; 2004 Dec; 39(12):1089-95. PubMed ID: 15571871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiotonic agents. 2. Synthesis and structure-activity relationships of 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones: a new class of positive inotropic agents.
    Sircar I; Duell BL; Bobowski G; Bristol JA; Evans DB
    J Med Chem; 1985 Oct; 28(10):1405-13. PubMed ID: 2864447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Substituted 4-, 5-, and 6-[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones and 2-substituted 4,5-bis[(1E)-3-oxo-3-phenylprop-1-en-1-yl]pyridazin-3(2H)-ones as potent platelet aggregation inhibitors: design, synthesis, and SAR studies.
    Meyers C; Yáñez M; Elmaatougi A; Verhelst T; Coelho A; Fraiz N; Lemière GL; García-Mera X; Laguna R; Cano E; Maes BU; Sotelo E
    Bioorg Med Chem Lett; 2008 Jan; 18(2):793-7. PubMed ID: 18053717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.